Delivery Order SPE2DB22D9316-SPE2DB24FYM63
Award Date 11/9/23
Potential Completion Date 12/4/23
Potential Value $9.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $19,518.56. The order is for the supply of TYSABRI 300 MG/15 ML VIAL 15ML to the Park Ridge, Illinois facility in support of DLA Troop Support Medical operations. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency valued at up to $5 million to provide pharmaceutical and medical supplies...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,759.28 by the Defense Logistics Agency Troop Support Medical to provide TYSABRI 300 MG/15 ML VIAL 15ML. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. This contract vehicle enables DLA to issue delivery orders on a firm fixed price basis for necessary...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,759.28 by the Defense Logistics Agency Troop Support Medical to provide Tysabri 300 mg/15 ml vials. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolam...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Tysabri 300 MG/15 ML vials. The $19,518.56 order has a completion date of November 17, 2023 and was awarded on October 26, 2023. DMS Pharmaceutical Group will supply the pharmaceutical item to DLA Troop Support Medical facilities from its location in Park Ridge, Illinois. As a woman-owned small business, DMS Pharmaceutical Group is...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $29,277.84. The order is for TYSABRI 300 MG/15 ML VIAL 15ML pharmaceutical products to support military treatment facilities. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler, holds an indefinite delivery contract with the Defense Logistics Agency valued at up to $5 million to provide atropine, Surgilube...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,759.28 by the Defense Logistics Agency Troop Support Medical to provide TYSABRI 300 MG/15 ML VIAL 15ML. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide TYSABRI 300 MG/15 ML VIAL 15ML pharmaceutical items. The $39,037.12 order has a completion date of January 5, 2024 and was awarded on December 13, 2023 without a set-aside designation. As a woman-owned small business and woman-owned business, DMS Pharmaceutical Group will fulfill the delivery order requirements...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-nine thousand thirty-seven dollars and twelve cents ($39,037.12) by the Defense Logistics Agency Troop Support Medical to provide TYSABRI 300 MG/15 ML VIAL 15ML pharmaceutical products. The delivery order was awarded on November 2, 2023 under the company's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to five million dollars through December...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,298.50 under the Defense Logistics Agency Troop Support Medical's indefinite delivery contract to provide pharmaceutical items. The order is for 8506260432 Typhoid VI Polysacc and will be completed by February 15, 2019. DMS Pharmaceutical Group will deliver the requested vaccine to the Defense Logistics Agency facility located in Park Ridge, Illinois. As a woman-owned small business, DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $52,627.70 firm fixed-price delivery order from the Defense Logistics Agency on September 4, 2025, for TYSABRI 300 mg/15 ml vials. The contract, with an ultimate completion date of September 25, 2025, carries no set-aside designation and represents performance at the company's Park Ridge, Illinois location. This delivery order falls under DMS Pharmaceutical Group's...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB24FYM63Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $9,759.28. The order is for the supply of TYSABRI 300 MG/15 ML VIAL 15ML to the Park Ridge, Illinois facility in support of DLA Troop Support Medical. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency through December 2025 to provide pharmaceuticals and medical supplies with a potential value of up to $5 million. As a woman-owned small business and pharmaceutical wholesaler, DMS Pharmaceutical Group has extensive experience supplying medical products to various military treatment facilities for the Department of Defense worldwide.
Generated 2/8/24, 10:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 11/9/23 |